ShowcasesPricing
  1. US-listed companies
  2. SUPERNUS PHARMACEUTICALS, INC.

SUPERNUS PHARMACEUTICALS, INC.SUPN

Market cap
$1.6B
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data